| Modification of lipid-based nanoparticles: an efficient delivery system for nucleic acid-based immunotherapy C Zhang, Y Ma, J Zhang, JCT Kuo, Z Zhang, H Xie, J Zhu, T Liu Molecules 27 (6), 1943, 2022 | 10 | 2022 |
| CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials Z Zhang, JCT Kuo, S Yao, C Zhang, H Khan, RJ Lee Pharmaceutics 14 (1), 73, 2021 | 10 | 2021 |
| Application of lipid-based nanoparticles in cancer immunotherapy Z Zhang, S Yao, Y Hu, X Zhao, RJ Lee Frontiers in Immunology 13, 2022 | 4 | 2022 |
| A squalene-based nanoemulsion for therapeutic delivery of resiquimod Z Zhang, JCT Kuo, C Zhang, Y Huang, Z Zhou, RJ Lee Pharmaceutics 13 (12), 2060, 2021 | 4 | 2021 |
| Ivermectin Enhanced Antitumor Activity of Resiquimod in a Co-Loaded Squalene Emulsion Z Zhang, JCT Kuo, C Zhang, Y Huang, RJ Lee Journal of Pharmaceutical Sciences 111 (11), 3038-3046, 2022 | 1 | 2022 |
| Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles Z Zhang, Y Huang, J Li, F Su, JCT Kuo, Y Hu, X Zhao, RJ Lee Advanced Healthcare Materials 12 (6), 2202412, 2023 | | 2023 |
